Genmark diagnostics, inc. (GNMK)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenue:
Product revenue

87,491

70,481

52,260

-

-

-

-

-

-

-

-

Sales Revenue, Goods, Net

-

-

-

48,914

39,029

30,328

27,204

20,211

4,700

2,341

911

Other revenue

530

278

259

360

382

266

200

258

309

223

88

Total revenue

88,021

70,759

52,519

49,274

39,411

30,594

27,404

20,469

5,009

2,564

999

Cost of revenue

59,418

51,278

32,514

19,700

15,317

13,127

15,570

11,640

6,206

3,979

4,332

Gross profit

28,603

19,481

20,005

29,574

24,094

17,467

11,834

8,829

-1,197

-1,415

-3,333

Operating expenses:
Sales and marketing

24,118

21,777

20,557

14,734

14,385

12,629

12,818

6,378

4,969

4,555

3,182

General and administrative

19,159

17,545

16,205

14,363

13,772

12,069

11,836

10,806

8,960

7,415

8,289

Research and development

27,140

27,931

42,760

49,458

37,472

31,823

22,060

13,536

8,737

6,646

5,634

Total operating expenses

70,417

67,253

79,522

78,555

65,629

56,521

46,714

30,720

22,666

18,616

17,105

Loss from operations

-41,814

-47,772

-59,517

-48,981

-41,535

-39,054

-34,880

-21,891

-23,863

-20,031

-20,438

Other income (expense):
Interest income

512

711

561

176

125

244

403

42

21

-

-

Foreign exchange gain (loss)

-

-

-

-

-

-

-

-

-

-1

304

Interest expense

5,961

3,108

3,042

1,536

880

20

19

90

95

-

-

Therapeutic discovery credit

-

-

-

-

-

-

-

-

-

1,644

-

Other expense

-23

-192

249

-160

133

-6

897

-16

19

-

-

Interest (expense) income, net

-

-

-

-

-

-

-

-

-

-

33

Total other expense

-5,472

-2,589

-2,232

-1,520

-622

218

1,281

-64

-55

1,643

337

Loss before provision for income taxes

-47,286

-50,361

-61,749

-50,501

-42,157

-38,836

-33,599

-21,955

-23,918

-18,388

-20,101

Income tax expense

64

139

101

100

40

-573

44

148

52

15

-138

Net loss

-47,350

-50,500

-61,850

-50,601

-42,197

-38,263

-33,643

-22,103

-23,970

-18,403

-19,963

Net loss per share, basic and diluted

-0.82

-0.91

-1.21

-1.15

-1.00

-0.93

-0.95

-0.84

-1.45

-1.88

-4.41

Weighted average number of shares outstanding, basic and diluted

57,603

55,669

51,169

44,100

42,157

41,346

35,253

26,215

16,572

9,797

-

Weighted average number of shares outstanding

-

-

-

-

-

-

-

-

-

-

4,527

Net loss

-47,350

-50,500

-61,850

-50,601

-42,197

-38,263

-33,643

-22,103

-23,970

-18,403

-19,963

Other comprehensive loss:
Foreign currency translation adjustments, net of tax

11

44

-

77

36

0

0

-

-

-35

-

Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)

11

44

-84

-

-

-

-

-

-

-

-

Net unrealized gains (losses) on marketable securities, net of tax

5

27

-2

-11

3

-20

-4

0

0

-

-

Total other comprehensive loss

16

71

-86

66

39

-38,283

-

-

-

-

-

Foreign currency translation adjustment, net of tax

-

-

-

-

-

-

-

-

14

-

-

Foreign currency translation adjustment

-

-

-

-

-

-

-

-

-

-

-93

Total comprehensive loss

-47,334

-50,429

-61,936

-50,535

-42,158

-

-33,647

-22,103

-23,956

-18,438

-20,056

AOCI Attributable to Parent [Member]
Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)

11

44

-84

-

-

-

-

-

-

-

-

Net unrealized gains (losses) on marketable securities, net of tax

5

27

-2

-

-

-

-

-

-

-

-